Black Seniors More Likely to Receive Low-Value Acute Diagnostic Tests
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 27, 2023 -- Older adult Black patients have higher adjusted receipt of nine low-value services, including acute diagnostic tests, and lower receipt of 20 services than White patients, according to a study published online Oct. 25 in The BMJ.
Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues characterized racial differences in receipt of low-value care among older Medicare beneficiaries in a retrospective cohort study involving 9,833,304 Black and White Medicare patients (6.8 percent Black) aged 65 years or older as of 2016. The main outcome measures were receipt of 40 low-value services.
The researchers found that compared with White patients, Black patients had higher adjusted receipt of nine services and lower receipt of 20 services. Black patients were more likely to receive low-value acute diagnostic tests, including imaging for uncomplicated headache and head computed tomography scans for dizziness (6.9 versus 3.2 percent and 3.1 versus 1.9 percent, respectively). Higher rates of low-value screening tests and treatments were seen for White patients, including preoperative laboratory tests (10.3 versus 6.5 percent), prostate-specific antigen (PSA) tests (31.0 versus 25.7 percent), and antibiotics for upper respiratory infections (36.6 versus 32.7 percent). These differences persisted within given health systems in secondary analyses and were not explained by receipt of care from different systems among Black and White patients.
"Even small differences might be clinically important because of the direct and indirect effects of low-value care, while the patterns across service categories suggest hypotheses about underlying mechanisms," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.